Back to MW MARSHALL WACE, LLP

BDTXBDTX
Showing 7 of 16 quarters

Position history for MWMARSHALL WACE, LLP's holdings in BLACK DIAMOND THERAPEUTICS I

MARSHALL WACE, LLP holds 896,602 shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $1.7M as of 2026-Q2. The position was increased (+7.2% shares). BDTX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1.7M

Current Shares

896,602

Total Value Change

+$1.2M

Total Shares Change

+799,436

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
896,602
+7.2%
$1.7M0.0%$1.85
28
2026-Q1
Decreased
836,266
-24.7%
$1.8M0.0%$2.30
0
2025-Q4
Decreased
1.1M
-14.6%
$2.7M0.0%$2.49
0
2025-Q3
Increased
1.3M
+76.1%
$4.9M0.0%$3.73
41
2025-Q2
New
737,875
-
$1.8M0.0%$2.35
36
2024-Q4
Exited
0
-100.0%
$00.0%$2.15
0
2024-Q3
Increased
97,166
+2.8%
$422,6720.0%$4.23
25

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used